The importance of biomarkers in determining the prognosis of patients requiring intensive care hospitalization due to COVID-19 infection COVID-19 mortality and biomarkers
Article Sidebar
Main Article Content
Abstract
Objective: This study aims to investigate the effect of biomarkers such as CRP, ferritin, troponin, lymphopenia, and D-dimer in predicting disease severity and clinical outcome. Identifying an effective and predictive biomarker will help to evaluate patients' risk and improve overall clinical management of patients with COVID-19
Material and Methods: In this retrospective cohort study, 1458 patients who were taken to intensive care follow-up due to COVID-19 across the province of Bursa were evaluated. Age, gender, and laboratory data such as ferritin, D-dimer, White Blood Cell (WBC), C-reactive protein, troponin values, chronic diseases, length of stay in the intensive care unit, and mortality were recorded. The relation of these variables with mortality was analyzed.
Results: There was no significant difference between the groups regarding age and length of stay in the intensive care unit (p=379, p=0.094). There was a statistically significant difference between the groups for ferritin, CRP, D-dimer, troponin, and WBC variables (p<0.001). In the ROC analysis, it was seen that the sensitivity value for ferritin was 86.08%, the specificity value was 85.23%, and the AUC: 0.902 had a high level of diagnostic value.
Conclusion: An increase in acute phase reactants was associated with mortality in patients followed up for COVID-19. This may be related to the increased cytokine response triggered by the disease.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2022-09-27
Published 2022-09-27
References
Wu Z, McGoogan JM: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama 2020, 323(13):1239-1242.
https://news.google.com/COVID19/map?hl=tr&mid=%2Fm%2F02j71&gl=TR&ceid=TR%3Atr access date:09.08.2022.
https://COVID19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html access date:09.032.2022.
https://apps.who.int/iris/handle/10665/330893 access date: 09.08.2022.
Kocayiğit, H., et al., Characteristics and outcomes of critically ill patients with COVID-19 in Sakarya, Turkey: asingle centre cohort study. Turkish journal of medical sciences, 2021. 51(2): p. 440-447.
Wu, Z. and J.M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama, 2020. 323(13): p. 1239-1242. DOI: https://doi.org/10.1001/jama.2020.2648
https://news.google.com/COVID19/map?hl=tr&mid=%2Fm%2F02j71&gl=TR&ceid=TR%3Atr access date:09.08.2022.
https://COVID19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html access date:09.032.2022.
https://apps.who.int/iris/handle/10665/330893 access date: 09.08.2022.
Kocayiğit, H., et al., Characteristics and outcomes of critically ill patients with COVID-19 in Sakarya, Turkey: asingle centre cohort study. Turkish journal of medical sciences, 2021. 51(2): p. 440-447. DOI: https://doi.org/10.3906/sag-2005-57
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669. PMID: 22797452. DOI: https://doi.org/10.1001/jama.2012.5669
Khwaja, A., KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice, 2012. 120(4): p. c179-c184. DOI: https://doi.org/10.1159/000339789
Livingston, E. and K. Bucher, Coronavirus Disease 2019 (COVID-19) in Italy. JAMA, 2020. 323(14): p. 1335-1335. DOI: https://doi.org/10.1001/jama.2020.4344
El Aidaoui, K., et al., Predictors of severity in COVID-19 patients in Casablanca, Morocco. Cureus, 2020. 12(9). DOI: https://doi.org/10.7759/cureus.10716
Garcia, P.D.W., et al., Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine, 2020. 25: p. 100449.
Guan, W.-j., et al., Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020. 382(18): p. 1708-1720. DOI: https://doi.org/10.1056/NEJMoa2002032
Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020. 395(10223): p. 497-506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Zhou, F., et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 2020. 395(10229): p. 1054-1062. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
Wang, B., et al., Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (albany NY), 2020. 12(7): p. 6049. DOI: https://doi.org/10.18632/aging.103000
Onder, G., G. Rezza, and S. Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama, 2020. 323(18): p. 1775-1776. DOI: https://doi.org/10.1001/jama.2020.4683
Griffith, D.M., et al., Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Preventing chronic disease, 2020. 17: p. E63. DOI: https://doi.org/10.5888/pcd17.200247
Regitz-Zagrosek, V. and G. Kararigas, Mechanistic pathways of sex differences in cardiovascular disease. Physiological reviews, 2017. 97(1): p. 1-37. DOI: https://doi.org/10.1152/physrev.00021.2015
McIntosh, K., M. Hirsch, and A. Bloom, Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. Lancet. Infect. Dis, 2020. 1: p. 2019-2020.
Shereen, M.A., et al., COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of advanced research, 2020. 24: p. 91-98. DOI: https://doi.org/10.1016/j.jare.2020.03.005
Vetter, P., et al., Clinical features of COVID-19. 2020, British Medical Journal Publishing Group. DOI: https://doi.org/10.1136/bmj.m1470
Bolondi, G., et al., Iron metabolism and lymphocyte characterisation during COVID-19 infection in ICU patients: an observational cohort study. World Journal of Emergency Surgery, 2020. 15(1): p. 1-8. DOI: https://doi.org/10.1186/s13017-020-00323-2
Kernan, K.F. and J.A. Carcillo, Hyperferritinemia and inflammation. International immunology, 2017. 29(9): p. 401-409. DOI: https://doi.org/10.1093/intimm/dxx031
Giemza-Stokłosa, J., M.A. Islam, and P.J. Kotyla, Hyperferritinaemia: an iron sword of autoimmunity. Current pharmaceutical design, 2019. 25(27): p. 2909-2918. DOI: https://doi.org/10.2174/1381612825666190709202804
Cassat, J.E. and E.P. Skaar, Iron in infection and immunity. Cell host & microbe, 2013. 13(5): p. 509-519. DOI: https://doi.org/10.1016/j.chom.2013.04.010
Drakesmith, H. and A. Prentice, Viral infection and iron metabolism. Nature Reviews Microbiology, 2008. 6(7): p. 541-552. DOI: https://doi.org/10.1038/nrmicro1930
Drakesmith, H. and A.M. Prentice, Hepcidin and the iron-infection axis. science, 2012. 338(6108): p. 768-772. DOI: https://doi.org/10.1126/science.1224577
Dhondt, N., et al., Childhood adversity and adolescent psychopathology: evidence for mediation in a national longitudinal cohort study. The British Journal of Psychiatry, 2019. 215(3): p. 559-564. DOI: https://doi.org/10.1192/bjp.2019.108
Litton, E. and J. Lim, Iron metabolism: an emerging therapeutic target in critical illness. Annual Update in Intensive Care and Emergency Medicine 2019, 2019: p. 573-584. DOI: https://doi.org/10.1007/978-3-030-06067-1_44
Fan, S.-L., et al., Diagnosing sepsis–the role of laboratory medicine. Clinica chimica acta, 2016. 460: p. 203-210. DOI: https://doi.org/10.1016/j.cca.2016.07.002
Gabay, C. and I. Kushner, Acute-phase proteins and other systemic responses to inflammation. New England journal of medicine, 1999. 340(6): p. 448-454. DOI: https://doi.org/10.1056/NEJM199902113400607
Ruan, Q., et al., Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 2020. 46(5): p. 846-848. DOI: https://doi.org/10.1007/s00134-020-05991-x
Jin, Y., et al., Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 2020. 12(4): p. 372. DOI: https://doi.org/10.3390/v12040372
Teijaro, J.R. Cytokine storms in infectious diseases. in Seminars in immunopathology. 2017. Springer. DOI: https://doi.org/10.1007/s00281-017-0640-2
Chen, T., et al., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj, 2020. 368. DOI: https://doi.org/10.1136/bmj.m1091
Yuki, K., M. Fujiogi, and S. Koutsogiannaki, COVID-19 pathophysiology: A review. Clinical immunology, 2020. 215: p. 108427. DOI: https://doi.org/10.1016/j.clim.2020.108427
Velavan, T.P. and C.G. Meyer, Mild versus severe COVID-19: laboratory markers. International Journal of Infectious Diseases, 2020. 95: p. 304-307.
Henry, B.M., COVID-19, ECMO, and lymphopenia: a word of caution. The Lancet Respiratory Medicine, 2020. 8(4): p. e24. DOI: https://doi.org/10.1016/S2213-2600(20)30119-3
Organization, W.H., Clinical management of severe acute respiratory infection when COVID-19 is suspected (v1. 2). 2020: 1-21.
Qin, C., et al., Desregulación de la respuesta inmune en pacientes con coronavirus 2019 (COVID-19) en Wuhan, China. Enfermedades infecciosas Infecciosas cClínicas, 2020. 71(15): p. 762-768.
Thirumalaisamy, P. and C. Meyer, Mild versus severe COVID-19: Laborytorma markers. Int. J. Infect. Dis, 2020. 95: p. 304-307. DOI: https://doi.org/10.1016/j.ijid.2020.04.061
Wang, W.-K., et al., Temporal relationship of viral load, ribavirin, interleukin (IL)—6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clinical infectious diseases, 2004. 39(7): p. 1071-1075. DOI: https://doi.org/10.1086/423808
Asghar, M.S., et al., Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country. Cureus, 2020. 12(8). DOI: https://doi.org/10.7759/cureus.9575
Rodelo, J.R., et al., D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. The American journal of emergency medicine, 2012. 30(9): p. 1991-1999. DOI: https://doi.org/10.1016/j.ajem.2012.04.033
Bhutta, Z.A., et al., COVID-19 risks and response in South Asia. 2020, British Medical Journal Publishing Group. DOI: https://doi.org/10.1136/bmj.m1190
Tang, N., et al., Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis, 2020. 18(4): p. 844-847. DOI: https://doi.org/10.1111/jth.14768
Hu, H., et al., Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin (published online ahead of print March 16, 2020). Eur Heart J.
Shi, S., et al., Cardiac injury in patients with corona virus disease 2019. JAMA Cardiol, 2020. 5(7): p. 802-810. DOI: https://doi.org/10.1001/jamacardio.2020.2456
Çelik, D. and Ş. Köse, Erişkinlerde COVID-19: klinik bulgular. Tepecik Eğit. ve Araşt. Hast. Dergisi, 2020. 30(2): p. 43-48.
Bai, Y., et al., Presumed asymptomatic carrier transmission of COVID-19. Jama, 2020. 323(14): p. 1406-1407. DOI: https://doi.org/10.1001/jama.2020.2565
Kochi, A.N., et al., Cardiac and arrhythmic complications in patients with COVID‐19. Journal of cardiovascular electrophysiology, 2020. 31(5): p. 1003-1008. DOI: https://doi.org/10.1111/jce.14479
Bansal, M., Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(3): p. 247-250. DOI: https://doi.org/10.1016/j.dsx.2020.03.013
Lippi, G., C.J. Lavie, and F. Sanchis-Gomar, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Progress in cardiovascular diseases, 2020. 63(3): p. 390. DOI: https://doi.org/10.1016/j.pcad.2020.03.001
Wang, D., et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 2020. 323(11): p. 1061-1069. DOI: https://doi.org/10.1001/jama.2020.1585
Liu, W., et al., Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese medical journal, 2020. 133(09): p. 1032-1038. DOI: https://doi.org/10.1097/CM9.0000000000000775
Zhu, N., et al., A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine, 2020. DOI: https://doi.org/10.1056/NEJMoa2001017
Bhatraju, P.K., et al., COVID-19 in critically ill patients in the Seattle region—case series. New England Journal of Medicine, 2020. 382(21): p. 2012-2022. DOI: https://doi.org/10.1056/NEJMoa2004500
Schädler, D., et al., The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PloS one, 2017. 12(10): p. e0187015. DOI: https://doi.org/10.1371/journal.pone.0187015
Yang, X., et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 2020. 8(5): p. 475-481. DOI: https://doi.org/10.1016/S2213-2600(20)30079-5
Clark, A., et al., Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet Global Health, 2020. 8(8): p. e1003-e1017. DOI: https://doi.org/10.1016/S2214-109X(20)30264-3
Luo, X., et al., Prognostic value of C-reactive protein in patients with coronavirus 2019. Clinical Infectious Diseases, 2020. 71(16): p. 2174-2179. DOI: https://doi.org/10.1093/cid/ciaa641
Zhang, J.-j., et al., Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 2020. 75(7): p. 1730-1741. DOI: https://doi.org/10.1111/all.14238
Ahmed, S., et al., Evaluation of serum ferritin for prediction of severity and mortality in COVID-19-A cross sectional study. Annals of medicine and Surgery, 2021. 63: p. 102163. DOI: https://doi.org/10.1016/j.amsu.2021.02.009
Cecconi, M., et al., Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for COVID-19 infection in Lombardy, Italy. Journal of clinical medicine, 2020. 9(5): p. 1548. DOI: https://doi.org/10.3390/jcm9051548
Wang, F., et al., Clinical characteristics of 28 patients with diabetes and COVID-19 in Wuhan, China. Endocrine Practice, 2020. 26(6): p. 668-674. DOI: https://doi.org/10.4158/EP-2020-0108
Zheng, Z., et al., Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of infection, 2020. 81(2): p. e16-e25. DOI: https://doi.org/10.1016/j.jinf.2020.04.021
Arentz, M., et al., Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama, 2020. 323(16): p. 1612-1614. DOI: https://doi.org/10.1001/jama.2020.4326
Bennouar, S., et al., Usefulness of biological markers in the early prediction of corona virus disease-2019 severity. Scandinavian Journal of Clinical and Laboratory Investigation, 2020. 80(8): p. 611-618. DOI: https://doi.org/10.1080/00365513.2020.1821396
Feld, J., et al., Ferritin levels in patients with COVID‐19: a poor predictor of mortality and hemophagocytic lymphohistiocytosis. International journal of laboratory hematology, 2020. 42(6): p. 773-779. DOI: https://doi.org/10.1111/ijlh.13309
Gómez-Pastora, J., et al., Hyperferritinemia in critically ill COVID-19 patients–is ferritin the product of inflammation or a pathogenic mediator? Clinica Chimica Acta; International Journal of Clinical Chemistry, 2020. 509: p. 249. DOI: https://doi.org/10.1016/j.cca.2020.06.033
Gülcher, S.S., et al., Elevated C-reactive protein levels at ICU discharge as a predictor of ICU outcome: a retrospective cohort study. Annals of intensive care, 2016. 6(1): p. 1-8. DOI: https://doi.org/10.1186/s13613-016-0105-0
Koozi, H., M. Lengquist, and A. Frigyesi, C-reactive protein as a prognostic factor in intensive care admissions for sepsis: A Swedish multicenter study. Journal of critical care, 2020. 56: p. 73-79. DOI: https://doi.org/10.1016/j.jcrc.2019.12.009
Henry, B.M., et al., Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM), 2020. 58(7): p. 1021-1028. DOI: https://doi.org/10.1515/cclm-2020-0369
Ullah, W., et al., Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19. Journal of community hospital internal medicine perspectives, 2020. 10(5): p. 402-408. DOI: https://doi.org/10.1080/20009666.2020.1798141
Cai, Q., et al., COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy, 2020. 75(7): p. 1742-1752. DOI: https://doi.org/10.1111/all.14309
Wan, S., et al., Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology, 2020. 92(7): p. 797-806. DOI: https://doi.org/10.1002/jmv.25783
Zhang, G., et al., Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. MedRxiv, 2020. DOI: https://doi.org/10.1101/2020.03.02.20030452
Rodriguez-Morales, A.J., et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease, 2020. 34: p. 101623. DOI: https://doi.org/10.1016/j.tmaid.2020.101623
He, Z., et al., Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. International journal of infectious diseases, 2005. 9(6): p. 323-330. DOI: https://doi.org/10.1016/j.ijid.2004.07.014
Lippi, G. and E.J. Favaloro, D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and haemostasis, 2020. 120(05): p. 876-878. DOI: https://doi.org/10.1055/s-0040-1709650
Sakka, M., et al., Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. JMV-Journal de Médecine Vasculaire, 2020. 45(5): p. 268-274. DOI: https://doi.org/10.1016/j.jdmv.2020.05.003
Tang, N., et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis, 2020. 18(5): p. 1094-1099. DOI: https://doi.org/10.1111/jth.14817
Zhang, L., et al., D‐dimer levels on admission to predict in‐hospital mortality in patients with COVID‐19. Journal of thrombosis and haemostasis, 2020. 18(6): p. 1324-1329. DOI: https://doi.org/10.1111/jth.14859
Panigada, M., et al., Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. Journal of thrombosis and haemostasis, 2020. 18(7): p. 1738-1742. DOI: https://doi.org/10.1111/jth.14850
Ranucci, M., et al., The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. Journal of Thrombosis and Haemostasis, 2020. 18(7): p. 1747-1751. DOI: https://doi.org/10.1111/jth.14854
Danzi, G.B., et al., Acute pulmonary embolism and COVID-19 pneumonia: a random association? European heart journal, 2020. 41(19): p. 1858-1858. DOI: https://doi.org/10.1093/eurheartj/ehaa254
Zhang, Y., et al., Coagulopathy and antiphospholipid antibodies in patients with COVID-19. New England Journal of Medicine, 2020. 382(17): p. e38. DOI: https://doi.org/10.1056/NEJMc2007575
Cui, S., et al., Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 2020. 18(6): p. 1421-1424. DOI: https://doi.org/10.1111/jth.14830
Klok, F., et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis research, 2020. 191: p. 145-147. DOI: https://doi.org/10.1016/j.thromres.2020.04.013
Wang, T., et al., Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. The Lancet Haematology, 2020. 7(5): p. e362-e363. DOI: https://doi.org/10.1016/S2352-3026(20)30109-5
Wibowo, A., et al., Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression. International Journal of Infectious Diseases, 2021. 105: p. 312-318. DOI: https://doi.org/10.1016/j.ijid.2021.02.113
Lombardi, C.M., et al., Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study. JAMA cardiology, 2020. 5(11): p. 1274-1280. DOI: https://doi.org/10.1001/jamacardio.2020.3538
McEvoy, J.W., et al., Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA cardiology, 2016. 1(5): p. 519-528. DOI: https://doi.org/10.1001/jamacardio.2016.0765
Pattanshetty, D.J., et al., Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis: a retrospective study. Journal of hypertension, 2012. 30(12): p. 2410-2415. DOI: https://doi.org/10.1097/HJH.0b013e3283599b4f
Segre, C.A.W., et al., Troponin in diabetic patients with and without chronic coronary artery disease. BMC cardiovascular disorders, 2015. 15(1): p. 1-6. DOI: https://doi.org/10.1186/s12872-015-0051-z
Zethelius, B.r., N. Johnston, and P. Venge, Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation, 2006. 113(8): p. 1071-1078. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.570762
Shi, S., et al., Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 2020. 5(7): p. 802-810. DOI: https://doi.org/10.1001/jamacardio.2020.0950
Pranata, R., I. Huang, and S.B. Raharjo, Incidence and impact of cardiac arrhythmias in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Indian pacing and electrophysiology journal, 2020. 20(5): p. 193-198. DOI: https://doi.org/10.1016/j.ipej.2020.08.001
Pranata, R., et al., Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgraduate Medical Journal, 2020. 96(1137): p. 387-391. DOI: https://doi.org/10.1136/postgradmedj-2020-137884